From GlobeNewswire: 2025-04-04 06:35:00

The Infectious Disease Diagnostics Market is projected to reach US$ 59.95 Million by 2030 with a CAGR of 5.7% from 2022. Key players include bioMerieux SA, DiaSorin SpA, and Roche Ltd. Major trends include molecular diagnostics, rapid diagnostics, and antimicrobial resistance diagnostics. North America led the market in 2022, with Asia Pacific expected to show the highest growth.

Technological advancements in diagnostic tools are driving growth in the infectious disease diagnostics market. New technologies like molecular diagnostics, PCR, point-of-care testing, and NGS are revolutionizing the identification and treatment of infectious diseases. The market is also boosted by the rising incidence of infectious diseases globally, including malaria, tuberculosis, HIV/AIDS, and hepatitis.

The field of microbial identification is evolving with technological improvements, such as PCR and NGS. AI and machine learning are also being used for data analysis. Regulatory constraints are increasing the demand for strong microbiological testing procedures in pharmaceuticals and food safety sectors. The market for Infectious Disease Diagnostics has a bright future due to regulatory compliance, technical breakthroughs, and increased public health awareness.

The report provides valuable insights for stakeholders to navigate the evolving market landscape and unlock new opportunities. Key segments include kits & reagents, instruments, and software & services. Technology segments include biosensor-based, immunodiagnostics, and molecular-based diagnostics. The market is segmented by application type, testing type, and end user. North America led in 2022, with Asia Pacific expected to show the highest growth.



Read more at GlobeNewswire: Infectious Disease Diagnostics Market Size to Reach USD